GI Alliance Research - Dallas

Clinical research site in Dallas, Texas

Part of GI Alliance Research

As of July 2026, 2 paid clinical trials are recruiting at GI Alliance Research - Dallas in Dallas, Texas. Active studies at this site cover conditions such as Metabolic Dysfunction Associated Steatohepatitis (MASH), Liver Fibrosis and Metabolic Dysfunction Associated Steatohepatitis. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at GI Alliance Research - Dallas (2)

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

for Metabolic Dysfunction Associated Steatohepatitis (MASH)

163 locations incl. Birmingham

Sponsor: Boehringer Ingelheim

Sex: All·Age: 18+

Code: NCT06632444·Phase 3·Recruiting·Listed Oct 2024

Apply to this trial

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

for Metabolic Dysfunction Associated Steatohepatitis

125 locations incl. Peoria

Sponsor: Boehringer Ingelheim

Sex: All·Age: 18+

Code: NCT06632457·Phase 3·Recruiting·Listed Oct 2024

Apply to this trial

More research sites in Dallas

University of Texas Southwestern Medical Center (189 trials)
UT Southwestern Medical Center (168 trials)
UT Southwestern/Simmons Cancer Center-Dallas (73 trials)
University of Texas Southwestern (63 trials)
Baylor University Medical Center (43 trials)
Medical City Dallas Hospital (26 trials)
The University of Texas Southwestern Medical Center (25 trials)
Parkland Memorial Hospital (24 trials)
Mary Crowley Cancer Research (23 trials)
UT Southwestern (23 trials)

Explore more

Paid clinical trials in Dallas, TX · Texas clinical trials